EMFLAZA® (deflazacort) is NOW indicated for the treatment of Duchenne muscular dystrophy in patients 2 YEARS OF AGE AND OLDER.
TAKE ADVANTAGE OF PTC Cares PATIENT ASSISTANCE PROGRAMS
Additional financial support is available to help you gain access to EMFLAZA® (deflazacort)
PTC Cares™ offers financial assistance programs that may be able to offer support to patients who qualify.
Copay Assistance Program*†
If you have commercial insurance and have out-of-pocket costs associated with EMFLAZA and qualify for assistance, PTC Cares will offer a copay assistance program.
Charitable Foundation Referrals*
If you need additional assistance or are recipients of state or federal insurance and qualify for assistance, PTC Cares may be able to help direct you to independent charitable patient assistance foundations that might be able to help you with out-of-pocket costs, as determined solely by the independent charitable foundations.
Patient Assistance Program*
For patients with no insurance coverage, PTC Cares may be able to provide free drug for those who qualify.
If the insurance decision is delayed, PTC Cares may offer the Bridge Program to minimize gaps in therapy.
*Low to no out-of-pocket costs for most patients who qualify.
†Not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid or Medicare (including Medicare Part D).